303 related articles for article (PubMed ID: 34955556)
21. Nucleoside Derived Antibiotics to Fight Microbial Drug Resistance: New Utilities for an Established Class of Drugs?
Serpi M; Ferrari V; Pertusati F
J Med Chem; 2016 Dec; 59(23):10343-10382. PubMed ID: 27607900
[TBL] [Abstract][Full Text] [Related]
22. Anti-hepatitis C virus activity of novel beta-d-2'-C-methyl-4'-azido pyrimidine nucleoside phosphoramidate prodrugs.
Rondla R; Coats SJ; McBrayer TR; Grier J; Johns M; Tharnish PM; Whitaker T; Zhou L; Schinazi RF
Antivir Chem Chemother; 2009 Oct; 20(2):99-106. PubMed ID: 19843980
[TBL] [Abstract][Full Text] [Related]
23. The enantioselectivity of enzymes involved in current antiviral therapy using nucleoside analogues: a new strategy?
Maury G
Antivir Chem Chemother; 2000 May; 11(3):165-89. PubMed ID: 10901289
[TBL] [Abstract][Full Text] [Related]
24. Metabolism of Nucleosides and Nucleotides Prodrugs.
De Schutter C; Ehteshami M; Hammond ET; Amblard F; Schinazi RF
Curr Pharm Des; 2017 Oct; ():. PubMed ID: 29022511
[TBL] [Abstract][Full Text] [Related]
25. Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses.
Eyer L; Nencka R; de Clercq E; Seley-Radtke K; Růžek D
Antivir Chem Chemother; 2018; 26():2040206618761299. PubMed ID: 29534608
[TBL] [Abstract][Full Text] [Related]
26. DNA polymerases of herpesviruses and their inhibitors.
Piret J; Boivin G
Enzymes; 2021; 50():79-132. PubMed ID: 34861944
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and biological evaluation of novel nucleoside and nucleotide analogues as agents against DNA viruses and/or retroviruses.
Hakimelahi GH; Ly TW; Moosavi-Movahedi AA; Jain ML; Zakerinia M; Davari H; Mei HC; Sambaiah T; Moshfegh AA; Hakimelahi S
J Med Chem; 2001 Oct; 44(22):3710-20. PubMed ID: 11606136
[TBL] [Abstract][Full Text] [Related]
28. Novel Nucleoside Analogues as Effective Antiviral Agents for Zika Virus Infections.
Bassetto M; Cima CM; Basso M; Salerno M; Schwarze F; Friese D; Bugert JJ; Brancale A
Molecules; 2020 Oct; 25(20):. PubMed ID: 33092055
[TBL] [Abstract][Full Text] [Related]
29. L-nucleosides: antiviral activity and molecular mechanism.
Gumina G; Chong Y; Choo H; Song GY; Chu CK
Curr Top Med Chem; 2002 Oct; 2(10):1065-86. PubMed ID: 12171513
[TBL] [Abstract][Full Text] [Related]
30. Selected nucleos(t)ide-based prescribed drugs and their multi-target activity.
Pastuch-Gawołek G; Gillner D; Król E; Walczak K; Wandzik I
Eur J Pharmacol; 2019 Dec; 865():172747. PubMed ID: 31634460
[TBL] [Abstract][Full Text] [Related]
31. Triazole nucleoside derivatives bearing aryl functionalities on the nucleobases show antiviral and anticancer activity.
Xia Y; Qu F; Peng L
Mini Rev Med Chem; 2010 Aug; 10(9):806-21. PubMed ID: 20482498
[TBL] [Abstract][Full Text] [Related]
32. Comparative evaluation of L-Fd4C and related nucleoside analogs as promising antiviral agents.
Chen SH
Curr Med Chem; 2002 May; 9(9):899-912. PubMed ID: 11966452
[TBL] [Abstract][Full Text] [Related]
33. Prodrugs of Nucleoside Triphosphates as a Sound and Challenging Approach: A Pioneering Work That Opens a New Era in the Direct Intracellular Delivery of Nucleoside Triphosphates.
Camarasa MJ
ChemMedChem; 2018 Sep; 13(18):1885-1889. PubMed ID: 30152096
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and biological evaluation of phosphorodiamidate prodrugs of antiviral and anticancer nucleosides.
McGuigan C; Bourdin C; Derudas M; Hamon N; Hinsinger K; Kandil S; Madela K; Meneghesso S; Pertusati F; Serpi M; Slusarczyk M; Chamberlain S; Kolykhalov A; Vernachio J; Vanpouille C; Introini A; Margolis L; Balzarini J
Eur J Med Chem; 2013; 70():326-40. PubMed ID: 24177359
[TBL] [Abstract][Full Text] [Related]
35. Lipophilic Triphosphate Prodrugs of Various Nucleoside Analogues.
Jia X; Schols D; Meier C
J Med Chem; 2020 Jul; 63(13):6991-7007. PubMed ID: 32515595
[TBL] [Abstract][Full Text] [Related]
36. Cell entry and export of nucleoside analogues.
Pastor-Anglada M; Cano-Soldado P; Molina-Arcas M; Lostao MP; Larráyoz I; Martínez-Picado J; Casado FJ
Virus Res; 2005 Feb; 107(2):151-64. PubMed ID: 15649561
[TBL] [Abstract][Full Text] [Related]
37. The synthesis and antiviral properties of acyclic nucleoside analogues with a phosphonomethoxy fragment in the side chain.
Khandazhinskaya A; Yasko M; Shirokova E
Curr Med Chem; 2006; 13(24):2953-80. PubMed ID: 17073640
[TBL] [Abstract][Full Text] [Related]
38. Sugar-modified nucleosides in past 10 years, a review.
Ichikawa E; Kato K
Curr Med Chem; 2001 Mar; 8(4):385-423. PubMed ID: 11172696
[TBL] [Abstract][Full Text] [Related]
39. [Antiviral activity of extracts of basidiomycetes and humic compounds substances against Human Immunodeficiency Virus (Retroviridae: Orthoretrovirinae: Lentivirus: Human immunodeficiency virus 1) and Herpes Simplex Virus (Herpesviridae: Simplexvirus: Human alphaherpesvirus 1)].
Nosik DN; Nosik NN; Teplyakova TV; Lobach OA; Kiseleva IA; Kondrashina NG; Bochkova MS; Ananko GG
Vopr Virusol; 2020 Nov; 65(5):276-283. PubMed ID: 33533211
[TBL] [Abstract][Full Text] [Related]
40. Developments in the chemistry and biology of 1,2,3-triazolyl-C-nucleosides.
Nascimento SMRD; Ferry A; Gallier F; Lubin-Germain N; Uziel J; Gonzales S; Miranda LSME
Arch Pharm (Weinheim); 2024 Mar; 357(3):e2300580. PubMed ID: 38150650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
